Follow
Anton Bespalov
Anton Bespalov
Managing Partner, Partnership for Assessment and Accreditation of Scientific Practice
Verified email at paasp.net - Homepage
Title
Cited by
Cited by
Year
Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests
IV Belozertseva, T Kos, P Popik, W Danysz, AY Bespalov
European neuropsychopharmacology 17 (3), 172-179, 2007
2252007
Glutamatergic (N-methyl-D-aspartate receptor) hypofrontality in schizophrenia: too little juice or a miswired brain?
GJ Marek, B Behl, AY Bespalov, G Gross, Y Lee, H Schoemaker
Molecular pharmacology 77 (3), 317-326, 2010
1882010
Metabotropic glutamate receptor (mGluR5) antagonist MPEP attenuated cue-and schedule-induced reinstatement of nicotine self-administration behavior in rats
AY Bespalov, OA Dravolina, I Sukhanov, E Zakharova, E Blokhina, ...
Neuropharmacology 49, 167-178, 2005
1502005
Naltrexone for heroin dependence treatment in St. Petersburg, Russia
EM Krupitsky, EE Zvartau, DV Masalov, MV Tsoi, AM Burakov, ...
Journal of substance abuse treatment 26 (4), 285-294, 2004
1502004
Generation and therapeutic efficacy of highly oligomer-specific β-amyloid antibodies
H Hillen, S Barghorn, A Striebinger, B Labkovsky, R Müller, V Nimmrich, ...
Journal of Neuroscience 30 (31), 10369-10379, 2010
1492010
Effect of memantine on cue-induced alcohol craving in recovering alcohol-dependent patients
EM Krupitsky, O Neznanova, D Masalov, AM Burakov, T Didenko, ...
American Journal of Psychiatry 164 (3), 519-523, 2007
1302007
Naltrexone with or without fluoxetine for preventing relapse to heroin addiction in St. Petersburg, Russia
EM Krupitsky, EE Zvartau, DV Masalov, MV Tsoy, AM Burakov, ...
Journal of substance abuse treatment 31 (4), 319-328, 2006
1282006
Anxiolytic-like effects of mGlu1 and mGlu5 receptor antagonists in rats
M Pietraszek, I Sukhanov, P Maciejak, J Szyndler, A Gravius, A Wisłowska, ...
European journal of pharmacology 514 (1), 25-34, 2005
1242005
Stimulation of the metabotropic glutamate 2/3 receptor attenuates social novelty discrimination deficits induced by neonatal phencyclidine treatment
S Harich, G Gross, A Bespalov
Psychopharmacology 192, 511-519, 2007
1172007
Improving target assessment in biomedical research: the GOT-IT recommendations
CH Emmerich, LM Gamboa, MCJ Hofmann, M Bonin-Andresen, O Arbach, ...
Nature reviews Drug discovery 20 (1), 64-81, 2021
1032021
mGlu1 receptor blockade attenuates cue-and nicotine-induced reinstatement of extinguished nicotine self-administration behavior in rats
OA Dravolina, ES Zakharova, EV Shekunova, EE Zvartau, W Danysz, ...
Neuropharmacology 52 (2), 263-269, 2007
1032007
Effect of 5-HT3 receptor antagonist MDL 72222 on behaviors induced by ketamine in rats and mice
T Kos, P Popik, M Pietraszek, D Schäfer, W Danysz, O Dravolina, ...
European Neuropsychopharmacology 16 (4), 297-310, 2006
1022006
Improving transparency and scientific rigor in academic publishing
EM Prager, KE Chambers, JL Plotkin, DL McArthur, AE Bandrowski, ...
Journal of neuroscience research 97 (4), 377-390, 2019
992019
Effects of nicotinic and NMDA receptor channel blockers on intravenous cocaine and nicotine self-administration in mice
EA Blokhina, VA Kashkin, EE Zvartau, W Danysz, AY Bespalov
European Neuropsychopharmacology 15 (2), 219-225, 2005
942005
Behavioral characterization of the mGlu group II/III receptor antagonist, LY-341495, in animal models of anxiety and depression
AY Bespalov, MM van Gaalen, IA Sukhotina, K Wicke, M Mezler, ...
European journal of pharmacology 592 (1-3), 96-102, 2008
782008
Effects of a positive allosteric modulator of group II metabotropic glutamate receptors, LY487379, on cognitive flexibility and impulsive-like responding in rats
A Nikiforuk, P Popik, KU Drescher, M van Gaalen, AL Relo, M Mezler, ...
Journal of Pharmacology and Experimental Therapeutics 335 (3), 665-673, 2010
772010
Excitatory amino acid receptor antagonist kynurenic acid attenuates rewarding potential of morphine
A Bespalov, M Dumpis, L Piotrovsky, E Zvartau
European journal of pharmacology 264 (3), 233-239, 1994
741994
Effects of abused drugs on thresholds and breaking points of intracranial self-stimulation in rats
A Bespalov, A Lebedev, G Panchenko, E Zvartau
European Neuropsychopharmacology 9 (5), 377-383, 1999
721999
Failed trials for central nervous system disorders do not necessarily invalidate preclinical models and drug targets
A Bespalov, T Steckler, B Altevogt, E Koustova, P Skolnick, D Deaver, ...
Nature Reviews Drug Discovery 15 (7), 516-516, 2016
702016
Intravenous self-administration of abused solvents and anesthetics in mice
EA Blokhina, OA Dravolina, AY Bespalov, RL Balster, EE Zvartau
European journal of pharmacology 485 (1-3), 211-218, 2004
662004
The system can't perform the operation now. Try again later.
Articles 1–20